Literature DB >> 14500484

Positive and negative cis-acting regulatory sequences control expression of leukotoxin in Actinobacillus actinomycetemcomitans 652.

Christine Mitchell1, Ling Gao, Donald R Demuth.   

Abstract

Integration of IS1301 into an AT-rich inverted repeat located upstream of the ltx operon was previously shown to confer a hyperleukotoxic phenotype in Actinobacillus actinomycetemcomitans IS1 (T. He, T. Nishihara, D. R. Demuth, and I. Ishikawa, J. Periodontol. 70:1261-1268, 1999), but the mechanism leading to increased leukotoxin production was not determined. We show that an IS1 ltx promoter::lacZ reporter construct expresses 12-fold higher levels of beta-galactosidase activity than a reporter containing the ltx promoter from A. actinomycetemcomitans 652, suggesting that IS1301 increases transcription of the ltx operon. Examination of the IS1301 sequence identified a potential outwardly directed promoter. However, site-specific mutagenesis of the -35 element of the putative promoter had no effect on the transcriptional activity of the IS1 reporter construct. Furthermore, reverse transcriptase PCR and real-time PCR experiments did not detect a transcript that was initiated within IS1301. These results suggest that increased expression of leukotoxin in strain IS1 does not arise from an outwardly directed IS1301 promoter. To determine how IS1301 alters transcriptional regulation of the ltx operon, cis-acting sequences that regulate leukotoxin expression were identified. The AT-rich sequence that resides downstream from the site of IS1301 insertion was shown to function as a positive cis-acting regulator of leukotoxin expression. This sequence resembles an UP element in its location, AT-rich content, and activity and is homologous to the consensus UP element sequence. In addition, a negative cis-acting sequence was identified upstream from the site of IS1301 insertion, and deletion of this region increased promoter activity by fourfold. Mobility shift experiments showed that this region bound to a protein(s) in extracts from A. actinomycetemcomitans 652. The specific sequences required for this interaction were localized to a 26-nucleotide segment of the ltx promoter that resides 17 bp upstream from the site of IS1301 insertion. Together, these results suggest that positive and negative cis-acting sequences regulate leukotoxin expression and that IS1301 may increase transcription of the ltx operon in A. actinomycetemcomitans IS1 by displacing a negative cis-acting regulator approximately 900 bp upstream from the basal elements of the ltx promoter.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500484      PMCID: PMC201044          DOI: 10.1128/IAI.71.10.5640-5649.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

1.  Bacterial promoter architecture: subsite structure of UP elements and interactions with the carboxy-terminal domain of the RNA polymerase alpha subunit.

Authors:  S T Estrem; W Ross; T Gaal; Z W Chen; W Niu; R H Ebright; R L Gourse
Journal:  Genes Dev       Date:  1999-08-15       Impact factor: 11.361

Review 2.  The interaction between RTX toxins and target cells.

Authors:  E T Lally; R B Hill; I R Kieba; J Korostoff
Journal:  Trends Microbiol       Date:  1999-09       Impact factor: 17.079

3.  An IS257-derived hybrid promoter directs transcription of a tetA(K) tetracycline resistance gene in the Staphylococcus aureus chromosomal mec region.

Authors:  A E Simpson; R A Skurray; N Firth
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

4.  Transcription from fusion promoters generated during transposition of transposon Tn4652 is positively affected by integration host factor in Pseudomonas putida.

Authors:  R Teras; R Hõrak; M Kivisaar
Journal:  J Bacteriol       Date:  2000-02       Impact factor: 3.490

5.  Actinobacillus actinomycetemcomitans immunosuppressive protein is a member of the family of cytolethal distending toxins capable of causing a G2 arrest in human T cells.

Authors:  B J Shenker; T McKay; S Datar; M Miller; R Chowhan; D Demuth
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

6.  A novel insertion sequence increases the expression of leukotoxicity in Actinobacillus actinomycetemcomitans clinical isolates.

Authors:  T He; T Nishihara; D R Demuth; I Ishikawa
Journal:  J Periodontol       Date:  1999-11       Impact factor: 6.993

7.  Conformational studies of Actinobacillus actinomycetemcomitans leukotoxin: partial denaturation enhances toxicity.

Authors:  J D Lear; D Karakelian; U Furblur; E T Lally; J C Tanaka
Journal:  Biochim Biophys Acta       Date:  2000-02-09

8.  Evidence for the role of highly leukotoxic Actinobacillus actinomycetemcomitans in the pathogenesis of localized juvenile and other forms of early-onset periodontitis.

Authors:  V I Haraszthy; G Hariharan; E M Tinoco; J R Cortelli; E T Lally; E Davis; J J Zambon
Journal:  J Periodontol       Date:  2000-06       Impact factor: 6.993

9.  Expression of the cytolethal distending toxin (Cdt) operon in Actinobacillus actinomycetemcomitans: evidence that the CdtB protein is responsible for G2 arrest of the cell cycle in human T cells.

Authors:  B J Shenker; R H Hoffmaster; T L McKay; D R Demuth
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

10.  Heterogeneity in the immune response to serotype b LPS of Actinobacillus actinomycetemcomitans in inbred strains of mice.

Authors:  T Kato; K Honma; A Yamanaka; T Miura; K Okuda
Journal:  FEMS Immunol Med Microbiol       Date:  2000-05
View more
  8 in total

Review 1.  Herpesvirus-bacteria synergistic interaction in periodontitis.

Authors:  Casey Chen; Pinghui Feng; Jørgen Slots
Journal:  Periodontol 2000       Date:  2020-02       Impact factor: 7.589

Review 2.  Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy.

Authors:  S C Kachlany
Journal:  J Dent Res       Date:  2010-03-03       Impact factor: 6.116

3.  Repression of aerobic leukotoxin transcription by integration host factor in Aggregatibacter actinomycetemcomitans.

Authors:  David Kolodrubetz; Linda Phillips; Alex Burgum
Journal:  Res Microbiol       Date:  2010-05-20       Impact factor: 3.992

4.  Mlc is a transcriptional activator with a key role in integrating cyclic AMP receptor protein and integration host factor regulation of leukotoxin RNA synthesis in Aggregatibacter actinomycetemcomitans.

Authors:  Catherine Childress; Leigh A Feuerbacher; Linda Phillips; Alex Burgum; David Kolodrubetz
Journal:  J Bacteriol       Date:  2013-03-08       Impact factor: 3.490

5.  Increased leukotoxin production: Characterization of 100 base pairs within the 530 base pair leukotoxin promoter region of Aggregatibacter actinomycetemcomitans.

Authors:  Vandana Sampathkumar; Senthil Kumar Velusamy; Dipti Godboley; Daniel H Fine
Journal:  Sci Rep       Date:  2017-05-15       Impact factor: 4.379

6.  A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies.

Authors:  Maria Jose Uria; Qian Zhang; Yanwen Li; Angel Chan; Rachel M Exley; Bridget Gollan; Hannah Chan; Ian Feavers; Andy Yarwood; Raquel Abad; Ray Borrow; Roland A Fleck; Barbara Mulloy; Julio A Vazquez; Christoph M Tang
Journal:  J Exp Med       Date:  2008-05-26       Impact factor: 14.307

7.  Leukotoxic activity of Aggregatibacter actinomycetemcomitans and periodontal attachment loss.

Authors:  Carola Höglund Åberg; Dorte Haubek; Francis Kwamin; Anders Johansson; Rolf Claesson
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

8.  Serotypes of Aggregatibacter actinomycetemcomitans in relation to periodontal status and assessment of leukotoxin in periodontal disease: A clinico-microbiological study.

Authors:  Sudhakar Shuntikudege Suprith; Swati Setty; Kishore Bhat; Srinath Thakur
Journal:  J Indian Soc Periodontol       Date:  2018 May-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.